HiActi® Recombinant Human IL-12 Protein,His tag 重组人白介素-12

Scan for product

HEK293表达系统癌症免疫治疗疫苗开发

Product no.90200ES Sizes3 options SourceYeasen · Official

Cat. No. 90200ES10

现货 $885.00

Qty 1

Enquire now

Enquire / bulk Compare

Specifications & Enquiry

Tick the specs you need to submit them together; or enquire one by one. Cat. numbers are carried into the RFQ.

Cat.No Spec Price Status

90200ES10 10 μg $885.00 现货 Enquire

90200ES60 100 μg $4,385.00 现货 Enquire

90200ES76 500 μg $13,155.00 现货 Enquire

Submit enquiry Price is on application; bulk sizes can be sampled on request.

Overview

Specifications

Brand翌圣生物 Yeasen

Cat.No90200ES

Specification高纯度、高活性、低内毒素、高批间一致性

Origin翌圣生物科技(上海)股份有限公司

技术平台 HEK293表达系统

应用方法 癌症免疫治疗研究应用 疫苗开发研究应用

适用物种种属人

检测方法 SDS-PAGE LAL法

生物特性参数 蛋白类型重组蛋白 种属来源人 (Human) 生物活性描述ED50 <20 ng/mL (cell proliferation assay using PHA-activated human PBL); specific activity >5 × 10^4 IU/mg 应用癌症免疫治疗；疫苗开发

技术参数浓度1 mg/ml 纯度> 95% as determined by SDS-PAGE 内毒素水平< 1.0 EU per μg by LAL method 分子量Predicted MW: 24.5 kDa (IL-12A) & 36.6 kDa (IL-12B); observed 35-40 kDa (IL-12A) & 40-55 kDa (IL-12B) under reducing condition 制剂形式Sterile PBS (pH 7.4) 活性>5 × 10^4 IU/mg 储存条件-25 ~ -15℃保存，有效期1年 表达系统HEK293 标签N-His 表达序列Arg23-Ser219(IL-12A)&Ile23-Ser328(IL-12B) Accession号P29459-1(IL-12A)&P29460-1(IL-12B) 外观Liquid